AKT1 and colorectal carcinoma: Apigenin showed dose-dependent activity on proliferation, migration and invasion in CRC, modulating signaling pathways such as JAK/STAT, PI3K/AKT, NF-κB, MAPK/ERK, and Wnt/β-catenin pathways [36,87].